Abiopharma

Clinical trial NCT06052631: start date: 2026-06-16 → 2026-06-17.

Clinical trial NCT06439524 updates: 1. completion date: 2026-08-15 → 2028-12-01 2. primary completion date: 2026-02-15 → 2028-06-30

Cheche Group Announces Results of Extraordinary General Meeting

APPlife Digital Solutions, Inc. Announces Reverse Stock Split

Comtech to Host Third Quarter Fiscal 2026 Earnings Conference Call on June 15, 2026

Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month

LIXTE Biotechnology to Acquire NOMAD Transportable Power Systems, the Market Leader in Mobile, Utility-Grade Battery Energy Storage Systems (BESS)

Quantum Cyber Terminates At-the-Market Facility, Citing Strengthened Financial Position and No Immediate Capital Needs

Gilead Mobilizes Rapid Donation of Remdesivir to Support Ebola Response, Building on Decade-Long Commitment to Outbreak Relief

Disc Medicine Presents Positive Clinical Updates at the 2026 European Hematology Association (EHA) Annual Meeting